Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial von Clarke, N.W., Ali, A., Ingleby, F.C., Hoyle, A., Amos, C.L., Attard, G., Brawley, C.D., Calvert, J., Chowdhury, S., Cook, A., Cross, W., Dearnaley, D.P., Douis, H., Gilbert, D., Gillessen, S., Jones, R.J., Langley, R.E., MacNair, A., Malik, Z., Mason, M.D., Matheson, D., Millman, R., Parker, C.C., Ritchie, A.W.S., Rush, H., Russell, J.M., Brown, J., Beesley, S., Birtle, A., Capaldi, L., Gale, J., Gibbs, S., Lydon, A., Nikapota, A., Omlin, A., O'Sullivan, J.M., Parikh, O., Protheroe, A., Rudman, S., Srihari, N.N., Simms, M., Tanguay, J.S., Tolan, S., Wagstaff, J., Wallace, J., Wylie, J., Zarkar, A., Sydes, M.R., Parmar, M.K.B., James, N.D.

Volltext

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: A... von Clarke, N.W., Ali, A., Ingleby, F.C., Hoyle, A., Amos, C.L., Attard, G., Brawley, C.D., Calvert, J., Chowdhury, S., Cook, A., Cross, W., Dearnaley, D.P., Douis, H., Gilbert, D., Gillessen, S., Jones, R.J., Langley, R.E., MacNair, A., Malik, Z., Mason, M.D., Matheson, D., Millman, R., Parker, C.C., Ritchie, A.W.S., Rush, H., Russell, J.M., Brown, J., Beesley, S., Birtle, A., Capaldi, L., Gale, J., Gibbs, S., Lydon, A., Nikapota, A., Omlin, A., O’Sullivan, J.M., Parikh, O., Protheroe, A., Rudman, S., Srihari, N.N., Simms, M., Tanguay, J.S., Tolan, S., Wagstaff, J., Wallace, J., Wylie, J., Zarkar, A., Sydes, M.R., Parmar, M.K.B., James, N.D.

Volltext

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: A... von Clarke, NW, Ali, A, Ingleby, FC, Hoyle, A, Amos, CL, Attard, G, Brawley, CD, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, DP, Douis, H, Gilbert, D, Gillessen, S, Jones, RJ, Langley, RE, MacNair, A, Malik, Z, Mason, MD, Matheson, D, Millman, R, Parker, CC, Ritchie, AWS, Rush, H, Russell, JM, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, JM, Parikh, O, Protheroe, A, Rudman, S, Srihari, NN, Simms, M, Tanguay, JS, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, MR, Parmar, MKB, James, ND, STAMPEDE investigators

Volltext

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial von Clarke, NW, Ali, A, Ingleby, FC, Hoyle, A, Amos, CL, Attard, G, Brawley, CD, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, DP, Douis, H, Gilbert, D, Gillessen, S, Jones, RJ, Langley, RE, MacNair, A, Malik, Z, Mason, MD, Matheson, D, Millman, R, Parker, CC, Ritchie, AWS, Rush, H, Russell, JM, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, JM, Parikh, O, Protheroe, A, Rudman, S, Srihari, NN, Simms, M, Tanguay, JS, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, MR, Parmar, MKB, James, ND

Volltext

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial von Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R J, Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D

Volltext

Red Tender Nodule on a Pregnant Patient von Brawley, Stephen C., MD, PhD, Rogers, Theodore H., DO

Volltext

Radiotherapy for metastatic prostate cancer – Authors' reply von Parker, CC, James, ND, Brawley, CD, Clarke, NW, Parmar, MKB

Volltext bestellen

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial von Parker, CC, James, ND, Brawley, CD, Clarke, NW, Ali, A, Amos, CL, Attard, G, Chowdhury, S, Cook, A, Cross, W, Dearnaley, DP, Douis, H, Gilbert, DC, Gilson, C, Gillessen, S, Hoyle, A, Jones, RJ, Langley, RE, Malik, ZI, Mason, MD, Matheson, D, Millman, R, Rauchenberger, M, Rush, H, Russell, JM, Sweeney, H, Bahl, A, Birtle, A, Capaldi, L, Din, O, Ford, D, Gale, J, Henry, A, Hoskin, P, Kagzi, M, Lydon, A, O’Sullivan, JM, Paisey, SA, Parikh, O, Pudney, D, Ramani, V, Robson, P, Srihari, NN, Tanguay, J, Parmar, MKB, Sydes, MR

Volltext bestellen

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial von Rush, HL, Murphy, L, Morgans, AK, Clarke, NW, Cook, AD, Attard, G, Macnair, A, Dearnaley, DP, Parker, CC, Russell, JM, Gillessen, S, Matheson, D, Millman, R, Brawley, CD, Pugh, C, Tanguay, JS, Jones, RJ, Wagstaff, J, Rudman, S, O'Sullivan, JM, Gale, J, Birtle, A, Protheroe, A, Gray, E, Perna, C, Tolan, S, McPhail, N, Malik, ZI, Vengalil, S, Fackrell, D, Hoskin, P, Sydes, MR, Chowdhury, S, Gilbert, DC, Parmar, MKB, James, ND, Langley, RE

Volltext bestellen

Bone metastatic burden as a predictor of survival benefit from prostate radiotherapy in newly-diagnosed metastatic prostate cancer von Ali, A, Hoyle, AP, Parker, CC, Brawley, CD, Cook, A, Amos, C, Calvert, J, Hassan, D, Mason, MD, Attard, G, Parmar, MKB, Sydes, M, James, ND, Clarke, NW, STAMPEDE investigators

Volltext bestellen

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer von Hoyle, AP, Ali, A, James, ND, Cook, A, Parker, CC, de Bono, JS, Attard, G, Chowdhury, S, Cross, WR, Dearnaley, DP, Brawley, CD, Gilson, C, Ingleby, F, Gillessen, S, Aebersold, DM, Jones, RJ, Matheson, D, Millman, R, Mason, MD, Ritchie, AWS, Russell, M, Douis, H, Parmar, MKB, Sydes, MR, Clarke, NW, STAMPEDE Investigators

Volltext bestellen

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: A... von Clarke, NW, Ali, A, Ingleby, FC, Hoyle, A, Amos, CL, Attard, G, Brawley, CD, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, DP, Douis, H, Gilbert, D, Gillessen, S, Jones, RJ, Langley, RE, MacNair, A, Malik, Z, Mason, MD, Matheson, D, Millman, R, Parker, CC, Ritchie, AWS, Rush, H, Russell, JM, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, JM, Parikh, O, Protheroe, A, Rudman, S, Srihari, NN, Simms, M, Tanguay, JS, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, MR, Parmar, MKB, James, ND, STAMPEDE investigators

Volltext bestellen

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial von Clarke, NW, Ali, A, Ingleby, FC, Hoyle, A, Amos, CL, Attard, G, Brawley, CD, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, DP, Douis, H, Gilbert, D, Gillessen, S, Jones, RJ, Langley, RE, MacNair, A, Malik, Z, Mason, MD, Matheson, D, Millman, R, Parker, CC, Ritchie, AWS, Rush, H, Russell, JM, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, JM, Parikh, O, Protheroe, A, Rudman, S, Srihari, NN, Simms, M, Tanguay, JS, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, MR, Parmar, MKB, James, ND

Volltext bestellen

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial von Parker, CC, James, ND, Brawley, CD, Clarke, NW, Hoyle, AP, Ali, A, Ritchie, AWS, Attard, G, Chowdhury, S, Cross, W, Dearnaley, DP, Gillessen, S, Gilson, C, Jones, RJ, Langley, RE, Malik, ZI, Mason, MD, Matheson, D, Millman, R, Russell, JM, Thalmann, GM, Amos, CL, Alonzi, R, Bahl, A, Birtle, A, Din, O, Douis, H, Eswar, C, Gale, J, Gannon, MR, Jonnada, S, Khaksar, S, Lester, JF, O’Sullivan, JM, Parikh, OA, Pedley, ID, Pudney, DM, Sheehan, DJ, Nair Srihari, N, Tran, ATH, Parmar, MKB, Sydes, MR, Systemic Therapy for Advanced or Metastatic Prostate cancer

Volltext bestellen

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society von Wolf, Andrew M.D., Fontham, Elizabeth T.H., Church, Timothy R., Flowers, Christopher R., Guerra, Carmen E., LaMonte, Samuel J., Etzioni, Ruth, McKenna, Matthew T., Oeffinger, Kevin C., Shih, Ya‐Chen Tina, Walter, Louise C., Andrews, Kimberly S., Brawley, Otis W., Brooks, Durado, Fedewa, Stacey A., Manassaram‐Baptiste, Deana, Siegel, Rebecca L., Wender, Richard C., Smith, Robert A.

Volltext

Effect of Dutasteride on the Risk of Prostate Cancer von Andriole, Gerald L, Bostwick, David G, Brawley, Otis W, Gomella, Leonard G, Marberger, Michael, Montorsi, Francesco, Pettaway, Curtis A, Tammela, Teuvo L, Teloken, Claudio, Tindall, Donald J, Somerville, Matthew C, Wilson, Timothy H, Fowler, Ivy L, Rittmaster, Roger S

Volltext

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer von Hoyle, Alex P., Ali, Adnan, James, Nicholas D., Cook, Adrian, Parker, Christopher C., de Bono, Johann S., Attard, Gerhardt, Chowdhury, Simon, Cross, William R., Dearnaley, David P., Brawley, Christopher D., Gilson, Clare, Ingleby, Fiona, Gillessen, Silke, Aebersold, Daniel M., Jones, Rob J., Matheson, David, Millman, Robin, Mason, Malcolm D., Ritchie, Alastair W.S., Russell, Martin, Douis, Hassan, Parmar, Mahesh K.B., Sydes, Matthew R., Clarke, Noel W.

Volltext

American Cancer Society lung cancer screening guidelines von Wender, Richard, Fontham, Elizabeth T. H., Barrera, Ermilo, Colditz, Graham A., Church, Timothy R., Ettinger, David S., Etzioni, Ruth, Flowers, Christopher R., Scott Gazelle, G., Kelsey, Douglas K., LaMonte, Samuel J., Michaelson, James S., Oeffinger, Kevin C., Shih, Ya‐Chen Tina, Sullivan, Daniel C., Travis, William, Walter, Louise, Wolf, Andrew M. D., Brawley, Otis W., Smith, Robert A.

Volltext

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial von Parker, Christopher C, James, Nicholas D, Brawley, Christopher D, Clarke, Noel W, Hoyle, Alex P, Ali, Adnan, Ritchie, Alastair W S, Attard, Gerhardt, Chowdhury, Simon, Cross, William, Dearnaley, David P, Gillessen, Silke, Gilson, Clare, Jones, Robert J, Langley, Ruth E, Malik, Zafar I, Mason, Malcolm D, Matheson, David, Millman, Robin, Russell, J Martin, Thalmann, George N, Amos, Claire L, Alonzi, Roberto, Bahl, Amit, Birtle, Alison, Din, Omar, Douis, Hassan, Eswar, Chinnamani, Gale, Joanna, Gannon, Melissa R, Jonnada, Sai, Khaksar, Sara, Lester, Jason F, O'Sullivan, Joe M, Parikh, Omi A, Pedley, Ian D, Pudney, Delia M, Sheehan, Denise J, Srihari, Narayanan Nair, Tran, Anna T H, Parmar, Mahesh K B, Sydes, Matthew R

Volltext

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society von Oeffinger, Kevin C, Fontham, Elizabeth T. H, Etzioni, Ruth, Herzig, Abbe, Michaelson, James S, Shih, Ya-Chen Tina, Walter, Louise C, Church, Timothy R, Flowers, Christopher R, LaMonte, Samuel J, Wolf, Andrew M. D, DeSantis, Carol, Lortet-Tieulent, Joannie, Andrews, Kimberly, Manassaram-Baptiste, Deana, Saslow, Debbie, Smith, Robert A, Brawley, Otis W, Wender, Richard

Volltext